Skip to main content

Healthy Males

8
Pipeline Programs
8
Companies
8
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
4
2
1
0
0
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
3100%
+ 7 programs with unclassified modality

Competitive Landscape

8 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
Treatment APhase 41 trial
Active Trials
NCT00902512Completed30Est. Apr 2009
Human BioSciences
Human BioSciencesWV - Martinsburg
3 programs
2
1
First InterventionPhase 21 trial
AcylinePhase 1/21 trial
AcylinePhase 1/21 trial
Active Trials
NCT01215292Completed46Est. Mar 2012
NCT00839319Completed59Est. Nov 2010
NCT00842751Completed11Est. Dec 2009
Quantum Genomics
Quantum GenomicsFrance - Paris
1 program
1
FiribastatPhase 1Small Molecule
Quotient Therapeutics
Quotient TherapeuticsMA - Cambridge
1 program
1
FiribastatPhase 1Small Molecule
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
1 program
1
NaloxonePhase 11 trial
Active Trials
NCT01367561Completed15Est. May 2003
Daewon Pharma
Daewon PharmaKorea - Hwaseong
1 program
1
Pelubiprofen IRPhase 11 trial
Active Trials
NCT01870102Completed
Genomics
GenomicsUK - Oxford
1 program
FiribastatPHASE_1Small Molecule1 trial
Active Trials
NCT03714685Completed12Est. Jun 2019
Qilu Pharmaceutical
Qilu PharmaceuticalChina - Jinan
1 program
QL1203PHASE_11 trial
Active Trials
NCT04234594Unknown94Est. Sep 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerTreatment A
Human BioSciencesFirst Intervention
Human BioSciencesAcyline
Human BioSciencesAcyline
Qilu PharmaceuticalQL1203
GenomicsFiribastat
Bausch HealthNaloxone

Clinical Trials (8)

Total enrollment: 267 patients across 8 trials

NCT00902512PfizerTreatment A

Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations

Start: Apr 2009Est. completion: Apr 200930 patients
Phase 4Completed
NCT00842751Human BioSciencesFirst Intervention

Oral T7 Oral Testosterone in Man

Start: Jul 2009Est. completion: Dec 200911 patients
Phase 2Completed
NCT01215292Human BioSciencesAcyline

ITT4 Intratesticular Hormonal Milieu in Man (ITT4)

Start: Jan 2011Est. completion: Mar 201246 patients
Phase 1/2Completed
NCT00839319Human BioSciencesAcyline

HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone

Start: Mar 2009Est. completion: Nov 201059 patients
Phase 1/2Completed
NCT01870102Daewon PharmaPelubiprofen IR

Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR and Pelubiprofen SR (as a Pelubiprofen 45 mg) Tablet in Healthy Subjects

Phase 1Completed
NCT04234594Qilu PharmaceuticalQL1203

Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.

Start: Oct 2019Est. completion: Sep 202094 patients
Phase 1Unknown
NCT03714685GenomicsFiribastat

Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations

Start: Feb 2019Est. completion: Jun 201912 patients
Phase 1Completed
NCT01367561Bausch HealthNaloxone

Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function

Start: Oct 2002Est. completion: May 200315 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.